GAS5 and hepatocellular carcinoma: In summary, to the best of our knowledge, this study is the first one highlighting the diagnostic value of plasma miR-23b-3p in untreated HCC and the determination of circulating GAS5, miR-126-3p and miR-23b-3p in HCC patients treated with sorafenib.